Research Support - Cancer Immunotherapy

REF. 26-083_SS_CM

About the research group

The Cancer Immunotherapy (CIT) group is part of the Cancer Immunotherapy Program (ProCURE) within the Molecular Mechanisms and Experimental Therapy in Oncology (ONCOBELL) program of the Cancer Department of the Bellvitge Biomedical Research Institute (IDIBELL). It is located at the Institut Català d'Oncologia - Hospital Duran i Reynals (L'Hospitalet de Llobregat, Barcelona) and is co-led by Dr. Ramón Alemany and Dr. Josep Maria Piulats. We are collaborating with Dr Salazar (colorectal cancer) Dr Moreno (Universal CaR-T development) and Dr Del Carpio (Sarcoma) in different projects. The CIT researches the development of new cancer treatments based on the administration of oncolytic viruses, adoptive cell therapy, and other strategies aimed at enhancing the immune system's response to tumors, with a particular focus on poorly immunogenic or "cold" tumors (colorectal cancer, prostate cancer, uveal melanoma, ovarian cancer, and sarcomas, among others).

About the role

The selected person will develop the translational research focused on the development of new immunotherapies based on tumor reactive TCRs, universal CAR-T cells and improving autologous adoptive T-cell therapies. In this project, we will select tumor targets and develop cellular therapies against colorectal, sarcoma and prostate tumors. We will expand our current research to improve the ex-vivo expansion of tumor infiltrating lymphocytes antigen recognizing tumor specific antigens, testis specific antigens (TSA) or human endogenous retroviruses (hERVs). Secondly, to identify and follow-up TSA/hERV reactive T-

cell clones in peripheral blood and to select, clone and characterize reactive T-cell receptors (TCRs) from T-cells recognizing testis-specific antigens to develop new therapeutic products. The role of the contracted technician will be to perform functional assays, cytometry analyses, cell culture and cellular-molecular protocols related to the project.

Job requirements

Professional experience

• Previous demonstrable experience as a research laboratory technician in Immunology, immunotherapy or oncology.

Education and training

•  Intermediate Vocational Training (CFGM) in Biology, Biosciences, Biotechnology, Biomedicine, Immunology, or related fields. 

Technical & soft skills

• Functional immune assays.
• Flow cytometry for immune phenotyping of human samples
• General molecular biology techniques (DNA/RNA extraction, RT-PCR, etc.)
• Database maintenance, interpretation and reporting
• Processing and bio banking of human samples

Languages

• Good command of the English language

We will value, but not required

• Teamwork oriented, with high capabilities to collaborate with different professional profiles.
• Good communication skills.
• Advanced training in Immunology or related fields will be positively valued.

What do we offer

•  No. of positions: 1
•  Estimated start date: 14/09/2026
•  Contract duration: Permanent by project
•  Estimated annual gross salary: 22.380€
•  You will be part of a multicultural team. We have a fun loving and friendly international work environment.
•  Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
•  Possibility to work some days in remote -Teleworking
•  26 working days of holiday per year
•  System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
•  Paid leave package
•  Benefits of constant training are offered
•  We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

Deadline: Please submit your application by  06/07/2026

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations:

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).